Xtandi (enzalutamide) was first approved in August 2012 for use in CRPC ... under review by Europe's medicines regulator the EMA.
Astellas confirmed this morning that the EMA has started its assessment ... options across the disease continuum.” Xtandi is currently approved in the US and Japan for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback